Target intelligence / Profile preview

Streptococcus pneumoniae serotype 11A capsular polysaccharide

Molecular classification
Capsular polysaccharide, Bacterial surface antigen, Other
01

Overview

The **Streptococcus pneumoniae serotype 11A capsular polysaccharide** is a complex carbohydrate structure forming the outermost layer of S. pneumoniae serotype 11A.[1][2][3][4][5] It is composed of a linear, tetrasaccharide backbone with a pendant phosphopolyalcohol and sites of O-acetylation that are serotype-defining.[1][3] The capsule is the bacterium’s main virulence determinant, essential for evading host immune defenses by shielding the organism from phagocytosis and complement-mediated killing.[1][5] The structure of the 11A capsule contains four O-acetylation sites, distinguished from closely related variants (11E, 11Av) by the acetylation patterns and function of the wcjE acetyltransferase gene.[2][3][5] Anti-capsular antibodies, elicited naturally or via vaccination, target this polysaccharide and enable immune clearance.[1][2] The capsule is the antigenic target of pneumococcal conjugate and polysaccharide vaccines; its structural features and variability can impact vaccine efficacy and lead to vaccine escape by novel variants.[3][5]

Other names
Pneumococcal serotype 11A capsuleStreptococcus pneumoniae 11A capsuleS. pneumoniae serotype 11A capsular polysaccharidePneumococcus serotype 11A capsular polysaccharide
02

Mechanism of action

Induction of antibody-mediated immune response

03

Biological functions

Immune evasionVirulence factorModulation of host immune response
04

Disease associations

InfectionPneumoniaInvasive pneumococcal disease
05

Safety considerations

Antigenic variability leading to vaccine escapePotential for serotype switching and emergence of non-vaccine types
06

Interacting drugs

Pneumococcal polysaccharide vaccines (e.g., PPSV23, PCV13)
07

Biomarkers

Serotype-specific anti-capsular antibodiesSerotype 11A presence as a marker in microbiological diagnostics

Beyond the preview

Go deeper on Streptococcus pneumoniae serotype 11A capsular polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae serotype 11A capsular polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call